Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
U.S. Army Medical Research and Materiel Command |
---|---|
Information provided by: | U.S. Army Medical Research and Materiel Command |
ClinicalTrials.gov Identifier: | NCT00584844 |
This study is designed to determine the safety and immunogenicity of a Live Francisella tularensis Vaccine
Condition | Intervention | Phase |
---|---|---|
Tularemia |
Biological: Live Francisella Tularensis Vaccine |
Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Longitudinal Phase 2 Study for the Continued Evaluation of the Safety and Immunogenicity of a Live Francisella Tularensis Vaccine, NDBR 101, Lot 4 |
Estimated Enrollment: | 500 |
Study Start Date: | October 2004 |
Estimated Study Completion Date: | April 2008 |
Estimated Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |
Study Objectives:
Ages Eligible for Study: | 17 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Maryland | |
U.S. Army Medical Research Institute of Infectious Diseases | |
Fort Detrick, Maryland, United States, 21702 |
Principal Investigator: | Robert Rivard, MD | USAMRIID Medical Division |
Responsible Party: | USAMRMC, USAMMDA ( Robert E. Miller, PhD, Sponsor Representative, Director, Division of Regulated Activities and Compliance ) |
Study ID Numbers: | A-12775, FY03-24 |
Study First Received: | December 20, 2007 |
Last Updated: | October 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00584844 |
Health Authority: | United States: Food and Drug Administration |
Live Vaccine Strain (LVS), Bacterial Infections, Ulceroglandular, Oculoglandular |
Bacterial Infections Tularemia Tick-Borne Diseases Gram-Negative Bacterial Infections |